What are the criteria for pediatric acute liver failure (ALF)?

Pediatric Acute Liver Failure (PALF) Criteria

Pediatric acute liver failure is defined by three essential components: (1) no known chronic liver disease, (2) liver-based coagulopathy unresponsive to parenteral vitamin K with INR ≥1.5-1.9 with clinical encephalopathy OR INR ≥2.0 regardless of encephalopathy presence, and (3) biochemical evidence of acute liver injury. 1

Core Diagnostic Criteria

The PALF longitudinal research study established entry criteria that serve as the operational definition for identifying children requiring focused diagnostic and management strategies:

1. Absence of Known Chronic Liver Disease

• No prior history of chronic hepatic dysfunction
• Acute onset of liver injury without pre-existing cirrhosis 1

2. Coagulopathy Requirements (Critical Component)

• Liver-based coagulopathy that does NOT respond to parenteral vitamin K administration
• INR thresholds:
  • INR 1.5-1.9 WITH clinical evidence of encephalopathy, OR
  • INR ≥2.0 regardless of encephalopathy presence 1

3. Biochemical Evidence of Acute Liver Injury

• Elevated transaminases (AST/ALT)
• Evidence of hepatocellular dysfunction 2, 3

Important Clinical Context

Why These Criteria Matter for Mortality

Children with PALF may experience rapid death, making early recognition critical. 1 The criteria are designed to identify children at high risk who require:

• Immediate multidisciplinary management
• Early contact with pediatric liver transplant centers
• Intensive monitoring for rapid clinical deterioration 1

Key Differences from Adult ALF

Pediatric criteria differ fundamentally because children, particularly very young ones, do not demonstrate classical features of encephalopathy. 4 This is why the definition was revised to include patients with advanced coagulopathy regardless of mental status—a significant number of these children will require transplant or die even without overt encephalopathy. 4

The INR Threshold Nuance

The dual INR threshold (1.5 vs 2.0) reflects disease severity:

• INR 1.5-1.9: Requires encephalopathy to meet criteria (earlier stage, neurologic involvement already present)
• INR ≥2.0: Meets criteria alone (more severe coagulopathy, high risk even without encephalopathy) 1, 2

Critical Pitfalls to Avoid

1. Vitamin K Responsiveness Must Be Tested

The coagulopathy must be unresponsive to parenteral vitamin K. 1 Do not diagnose PALF based on INR alone without administering vitamin K first—this distinguishes true hepatocellular synthetic failure from nutritional deficiency.

2. PT/INR Limitations in PICU Patients

Recent evidence shows PT and INR cannot specifically represent liver synthetic function in some PICU patients, particularly those with sepsis, shock, or hemophagocytic syndrome. 5 The current diagnostic criteria have limitations when PALF occurs as a complication of other critical illnesses rather than as the primary diagnosis.

3. Encephalopathy Assessment in Young Children

Hepatic encephalopathy is difficult to assess in infants and young children. Look for:

• Altered sleep-wake cycles
• Irritability or lethargy
• Poor feeding
• Developmental regression
• Subtle changes in behavior reported by parents 4

Immediate Actions Upon Diagnosis

Once PALF criteria are met:

1. Urgent referral to pediatric liver transplant center (Grade 1-B recommendation) 1
2. Establish etiology to identify treatable conditions (herpes simplex, gestational alloimmune liver disease, autoimmune hepatitis, Wilson's disease) or contraindications to transplant 1
3. Multidisciplinary team involvement: pediatric gastroenterologist with liver expertise, intensive care specialist, liver transplant surgeon 1

Age-Specific Red Flags

• Child >5 years with ALF + Coombs-negative hemolytic anemia + low/normal alkaline phosphatase: Suspect Wilson's disease (poor prognosis, requires urgent plasma exchange and chelation) 1
• Infants <1 year: Consider metabolic diseases, infectious etiologies (HSV), gestational alloimmune liver disease 1

Prognostic Considerations

Disease severity scores fall short in predicting likelihood of death for individual patients, raising the possibility that some children may survive without transplant. 1 However, children with indeterminate diagnosis are more likely to require liver transplantation. 1

Stage 4 hepatic encephalopathy is an independent risk factor for failure of conventional treatment (OR=84.16,95%CI 4.04-1752.37). 5 This represents the point where transplant evaluation becomes most urgent.